1. 2019
  2. Iodinated anti-HER2 sdAb effectively targets and treats HER2 positive brain lesions

    Puttemans, J., D'Huyvetter, M., Lahoutte, T. & Devoogdt, N., 5 Sep 2019.

    Research output: Unpublished contribution to conferencePosterResearch

  3. Size And Affinity Kinetics Of Nanobodies Influence Penetration And Targeting Of Solid Tumours

    Debie, P., Lafont, C., Defrise, M., Hansen, I., van Willigen, D. M., van Leeuwen, F. WB., Gijsbers, R., D'Huyvetter, M., Devoogdt, N., Mollard, P. & Hernot, S., 5 Sep 2019.

    Research output: Unpublished contribution to conferencePosterResearch

  4. Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases

    Puttemans, J., Lahoutte, T., D'Huyvetter, M. & Devoogdt, N., 1 Aug 2019, In : Pharmaceutics. 11, 8, 23 p., 376.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  5. Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior

    Dekempeneer, Y., Back, T., Aneheim, E., Jensen, H., Puttemans, J., Xavier, C., Keyaerts, M., Palm, S., Albertsson, P., Lahoutte, T., Caveliers, V., Lindegren, S. & D'Huyvetter, M., Aug 2019, In : Molecular Pharmaceutics. 16, 8, p. 3524-3533

    Research output: Contribution to journalArticleResearchpeer-review

  6. CAM-H2 effectively targets and treats HER2 positive brain lesions: a comparative preclinical study with Trastuzumab.

    Puttemans, J., D'Huyvetter, M., Windhorst, AD., Lahoutte, T. & Devoogdt, N., 2 May 2019.

    Research output: Unpublished contribution to conferencePosterResearch

  7. CAM-H2 effectively targets and treats HER2 positive brain lesions: A comparative preclinical study with trastuzumab

    Puttemans, J., D'Huyvetter, M., Windhorst, B., Lahoutte, T. & Devoogdt, N., May 2019, In : Annals of Oncology. 30

    Research output: Contribution to journalMeeting abstract (Journal)Research

  8. Combining Bismuth-213 with Nanobodies: Finding the Perfect Match for Targeted Alpha Therapy

    Dekempeneer, Y., Caveliers, V., D'Huyvetter, M., Maertens, D., Gysemans, M., Ooms, M., Lahoutte, T., Xavier, C., Bruchertseifer, F., Morgenstern, A. & Cardinaels, T., 23 Mar 2019, Journal of Medical Imaging and Radiation Sciences. 1 ed. Elsevier, Vol. 50. p. S7-S8 2 p.

    Research output: Chapter in Book/Report/Conference proceedingConference paperResearch

  9. The Therapeutic Potential of Anti-HER2 2Rs15d Nanobody Labeled with 225Ac – an In Vitro and In Vivo Evaluation

    Pruszyński, M., D'Huyvetter, M., Rodak, M., Dekempeneer, Y., Lahoutte, T., Cedrowska, E., Bruchertseifer, F. & Morgenstern, A., 23 Mar 2019, Journal of Medical Imaging and Radiation sciences. 1 ed. Elsevier, Vol. 50. p. S7-S7 1 p.

    Research output: Chapter in Book/Report/Conference proceedingConference paperResearch

  10. 2018
  11. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20

    Krasniqi, A., Bialkowska, M., Xavier, C., Van der Jeught, K., Muyldermans, S., Devoogdt, N. & D'Huyvetter, M., 25 Oct 2018, In : New Biotechnology. 45, p. 69-79 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 9 Next

ID: 118617